Professor Arduino Mangoni

Strategic Professor and Head of Clinical Pharmacology

College of Medicine and Public Health

place Flinders Medical Centre (6D:302)
GPO Box 2100, Adelaide 5001, South Australia
Arduino trained in Clinical Pharmacology, Cardiology and Internal Medicine in Milan, Boston and London. In 2003 he was awarded a PhD at King's College London and was appointed as Senior Lecturer in the Department of Clinical Pharmacology at Flinders University. He was promoted to Associate Professor in 2007 before taking up the Chair of Medicine of Old Age at the University of Aberdeen in 2010. In 2013 he returned to Flinders University as Professor of Clinical Pharmacology and Senior Consultant in Clinical Pharmacology and Internal Medicine. 
Qualifications
MD(Hons), University of Milan, 1991
PhD, King's College London, 2003
MRCP(UK), 2003
FRACP, 2005
FRCP (London), 2009
FRCP (Glasgow), 2010
FRCP (Edinburgh), 2011
Honours, awards and grants

Kathleen Knights, Karen Lillywhite, Gail Easterbrook, John Miners and Arduino Mangoni, Carrick citation for outstanding contributions to student learning "For promotion of safe and effective medication management through an innovative e-learning pharmacology course for Nurse Practitioners in urban, rural and remote areas of Australia". (2007)

Visiting Professor, University of Sassari, Italy (2012, 2014, 2015)

Grants:

2014: A Pilotto, M Mirandola, S Menichelli, I Jansson, M Nordenfelt, M Zoratti, S Maggi, L Ferrucci, AA Mangoni, RJ Woodman, F Pellegrini, A Greco, D Sancarlo, K Kinder, H Kolk, AS Parent, I Kiss, I Petrov. Using Multidimensional Prognostic Indices (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons. European Commission, Second Health Programme (2008-2013), Ref: 508379, 3 years, EUR 837,572.

2014: MG Burt, CH Thompson, A Rowland, S Quinn, AA Mangoni. Does variability in glucocorticoid homeostasis affect insulin sensitivity and vascular function? Diabetes Australia, 1 year, $59,843

2015: AA Mangoni, A Rowland, J Miners, T Chataway, M Michael, MG Burt, D Keating, L Thurgood, M Sorich. Establishment of the Flinders Metabolomic Research facility. Flinders Faculty of Health Sciences Small Grants, AUD 20,000.

2015: MG Burt, AA Mangoni, L Heilbronn. Determination of the effect of relative hyperglycaemia on markers of cardiovascular risk. Flinders Faculty of Health Sciences Small Grants, AUD 19,000.

2015:  MG Burt, AA Mangoni, L Heilbronn. Determination of the effect of relative hyperglycaemia on markers of cardiovascular risk. Flinders Faculty of Health Sciences Small Grants, AUD 19,000.

2017:  Mangoni AA, Woodman RJ, Shanahan EM, Wiese MD. Effects of methotrexate on blood pressure and arterial function in rheumatoid arthritis. Investigator initiated trial research grant. medac Gesellschaft für klinische Spezialpräparate mbH (Germany), 3 years, AUD 550,000.

Research expertise
Cardiovascular medicine and haematology
Pharmacology and pharmaceutical sciences
Research interests
Arginine metabolomics in health and disease
Novel DDAH inhibitors as therapeutic agents in models of neurodegeneration
Cardiovascular toxicity of NSAIDs
Pharmacoepidemiology of antimuscarinic drugs and adverse effects in older patients
Topic coordinator
MMED8203 Knowledge of Health and Illness 2
Supervisory interests
Cardiovascular and internal medicine
Clinical biochemistry
Clinical pharmacology
Hypertension/cardiology
Pharmacological interventions on cardiovascular function
Structure/function of vascular beds
Higher degree by research supervision
Current
Principal supervisor: Pharmacology (3)
Associate supervisor: Endocrinology (1)
Completion
Principal supervisor: Design of novel DDAH inhibitors (Univ of Aberdeen) (1), Methotrexate and markers of cardiovascular risk in rheumatoid arthritis (Univ of Aberdeen) (1)
Associate supervisor: Pharmacology (3)
Publications